Can Leg Swelling Turn Into "Fat"? How Chronic Venous Insufficiency Remodels the Tissue Under the Skin

"My legs swelled up, and now it feels as if it has turned into fat."

It is something we hear often in clinic. At first the legs swell only in the evening. Then the swelling stops clearing by morning. Eventually the lower leg becomes hard and thick, and no amount of dieting changes it.

This article follows the mechanism by which chronic venous insufficiency (CVI) changes the tissue of the leg — step by step, with the evidence for each step.

Step 1: reflux → venous hypertension

Everything begins with abnormally high pressure inside the veins. When the valves fail, blood refluxes and ambulatory venous hypertension develops. In their 2021 review in the Journal of Clinical Medicine, Ortega and colleagues describe this sustained venous hypertension as the trigger for the microcirculatory changes, inflammation, hypoxia and vein wall remodelling that characterise chronic venous disease. Bergan and colleagues' 2008 review of animal models in the Journal of Vascular Surgery showed that elevated venous pressure and altered flow set off inflammatory cascades in the vein wall and valves, leading to progressive valve incompetence — and that these same processes are important in the skin changes of venous disease.

Step 2: capillary leak → oedema

The raised pressure is transmitted to the microcirculation. Capillary hydrostatic pressure rises and plasma components move out into the tissue. As Perrin and Ramelet set out in the European Journal of Vascular and Endovascular Surgery in 2011, the haemodynamic changes in the veins are transmitted to the microcirculation, causing capillary alteration that leads to oedema, skin changes and eventually ulceration. What leaks out is not simply water: it includes protein, red blood cells, fibrin and inflammatory mediators. This is where swelling begins.

Step 3: leukocyte trapping → chronic inflammation

The extravasated protein, red cells and the haemosiderin left behind when those cells break down are powerful inflammatory stimuli. Silverberg and colleagues, in their 2023 review of stasis dermatitis, describe leukocyte trapping: venous hypertension activates the endothelium, adhesion molecules such as ICAM-1 and VCAM-1 are upregulated, and white blood cells accumulate in the perivascular tissue and begin a sustained inflammatory process. Activated macrophages release cytokines (IL-1β, TNF-α) and matrix metalloproteinases (MMPs), and tissue breakdown proceeds.

Step 4: chronic inflammation → fibrosis → change in the fat layer

When inflammation persists for months to years, the body mounts a repair response. TGF-β1 activates fibroblasts, which over-produce collagen, and the tissue becomes fibrotic. As Raffetto and colleagues describe in their 2020 overview of venous ulcer pathophysiology, this fibrotic remodelling involves the skin and the subcutaneous tissue beneath it. Collagen is deposited into the fat layer, and what was once soft adipose tissue is progressively replaced by firm fibrous tissue. Fat cells lose normal function in the chronically hypoxic, cytokine-rich environment, and the surrounding progenitor cells are pushed toward a collagen-secreting, fibroblast-like behaviour.

Step 5: lipodermatosclerosis

The end result of this sequence is lipodermatosclerosis (CEAP C4b). The lower leg becomes hard, pigmented brown to red-brown, the ankle narrows while the calf stays swollen, and the leg takes on the shape of an inverted champagne bottle. Krizanova and colleagues, in the International Wound Journal, describe it as one stage in the cascade — blood pooling, hypoxia, inflammation, swelling, skin changes — that in severe cases ends in venous leg ulcer. The literature reviewed by Silverberg's group reports that adhesion molecule expression in lipodermatosclerotic skin is stronger than in the earlier oedematous stage.

Why dieting does not help

A leg that has thickened at the lipodermatosclerosis stage has not accumulated fat. The fat layer has been replaced by fibrotic tissue, and cutting calories does nothing to that hard tissue. In obesity, triglyceride accumulates inside fat cells; in chronic venous insufficiency, the fat layer itself has been transformed by inflammation and fibrosis. The mechanisms are entirely different.

Why timing matters

At the early oedema stage, treating the refluxing vein relieves the venous hypertension and the tissue can recover. At the lipodermatosclerosis stage, fibrotic tissue does not fully return to normal. The practical message is not to treat swelling as "just a bit of puffiness." The point at which swelling becomes recurrent and stops clearing overnight is the point to see a vein specialist.

In closing

Leg swelling is not simply fluid. Through the sequence venous hypertension → capillary leak → leukocyte trapping → chronic inflammation → fibrosis → transformation of the fat layer, swelling eventually changes the tissue itself. Early treatment is worth considering on exactly that basis: that what is treated now is tissue that can still recover.

---

References

• Ortega MA, Fraile-Martínez O, García-Montero C, et al. Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management. J Clin Med. 2021;10(15):3239. (PMID: 34362022)
• Bergan JJ, Pascarella L, Schmid-Schönbein GW. Pathogenesis of primary chronic venous disease: Insights from animal models of venous hypertension. J Vasc Surg. 2008;47(1):183-92. (PMID: 18178472)
• Silverberg J, Jackson JM, Kirsner RS, et al. Narrative Review of the Pathogenesis of Stasis Dermatitis: An Inflammatory Skin Manifestation of Venous Hypertension. Dermatol Ther (Heidelb). 2023;13(4):935-950. (PMID: 36949275)
• Raffetto JD, Ligi D, Maniscalco R, Khalil RA, Mannello F. Why Venous Leg Ulcers Have Difficulty Healing: Overview on Pathophysiology, Clinical Consequences, and Treatment. J Clin Med. 2020;10(1):29. (PMID: 33374372)
• Krizanova O, Penesova A, Hokynkova A, et al. Chronic venous insufficiency and venous leg ulcers: Aetiology, on the pathophysiology-based treatment. Int Wound J. 2024;21(2):e14405. (PMID: 37858977)
• Perrin M, Ramelet AA. Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions. Eur J Vasc Endovasc Surg. 2011;41(1):117-25. (PMID: 21126890)